A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Clinical trial NCT06948318 · RECRUITING

Trial details

NCT number: NCT06948318
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenic Purpura (ITP)

Start date: 2025-08-14
Primary completion: 2029-07-29
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.